The ATRT-MYC subgroup (23%) is named due to the overexpression of the MYC oncogene, not to be confused with MYCN, a tissue-specific transcription factor typically found during early development and is found to be overexpressed in the ATRT-SHH subgroup and other pediatric solid tumors such as neuroblastoma. Here, MYC is linked to neuroblastoma.